Friday, 9 May 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 09 May 2025
News

AZ unveils monster US$80B target

Posted 22 May 2024 PM

Overnight AstraZeneca unveiled its "bold ambition" to deliver US$80 billion in total revenue by the end of decade with the launch of 20 new medicines.

In announcing "the new era of growth" AstraZeneca's CEO, Pascal Soriot said many of the products have "the potential to generate more than US$5 million in peak year revenues".

To see the whole article, please login

Popular

What downturn? Pharma is back
How leaders can fix disengagement
Who's industry's 'Most Influential'?
Drug flood overwhelming HCPs
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home